31910-18-6

Basic information

• Product Name: 2,3-DIHYDROXY-6-METHOXYQUINOXALINE
• Synonyms: TIMTEC-BB SBB000304;ZERENEX E/6026569;2,3-DIHYDROXY-6-METHOXYQUINOXALINE;6-METHOXYQUINOXALINE-2,3-DIOL;2,3-Dihydoxy-6-methoxyquinoxaline;2,3-Quinoxalinedione, 1,4-dihydro-6-Methoxy-;6-Methoxy-1,4-dihydro-quinoxaline-2,3-dione;6-methoxy-1,4-dihydroquinoxaline-2,3-quinone
• CAS NO: 31910-18-6
• Molecular Formula: C₉H₈N₂O₃
• Molecular Weight: 192.17
• EINECS: 1312995-182-4
• Mol File: 31910-18-6.mol
• Article Data: 23

Chemical Properties

• Melting Point: 350 °C
• Boiling Point: 491.1 °C at 760 mmHg
• Flash Point: 250.8 °C
• Appearance: /
• Density: 1.322 g/cm³
• Vapor Pressure: 2.87E-10mmHg at 25°C
• Refractive Index: 1.566
• Storage Temp.: 2-8°C
• PKA: 9.97±0.20(Predicted)
• CAS DataBase Reference: 2,3-DIHYDROXY-6-METHOXYQUINOXALINE(CAS DataBase Reference)
• NIST Chemistry Reference: 2,3-DIHYDROXY-6-METHOXYQUINOXALINE(31910-18-6)
• EPA Substance Registry System: 2,3-DIHYDROXY-6-METHOXYQUINOXALINE(31910-18-6)

Safety Data

• Hazard Codes: Xi
• Hazardous Substances Data: 31910-18-6(Hazardous Substances Data)

Usage

Description

2,3-DIHYDROXY-6-METHOXYQUINOXALINE, also known as 6-Methoxyquinoxaline-2,3-diol, is an organic compound with a quinoxaline structure featuring two hydroxyl groups at the 2nd and 3rd positions and a methoxy group at the 6th position. It is characterized by its potential applications in various fields, particularly in pharmaceutical research and development.

Uses

Used in Pharmaceutical Research:
2,3-DIHYDROXY-6-METHOXYQUINOXALINE is used as a reagent for the discovery of MK-5172 (M424985), a macrocyclic analog that serves as an antiviral protease inhibitor. 2,3-DIHYDROXY-6-METHOXYQUINOXALINE plays a crucial role in the development of new antiviral drugs, particularly those targeting protease enzymes, which are essential for the replication and survival of certain viruses.

InChI:InChI=1/C9H8N2O3/c1-14-5-2-3-6-7(4-5)11-9(13)8(12)10-6/h2-4H,1H3,(H,10,12)(H,11,13)

Upstream product

• 95-92-1 oxalic acid diethyl ester 
• 102-51-2 4-methoxy-1,2-phenylenediamine 
• 39266-92-7 6-methoxyquinoxaline 1,4-dioxide 
• 6153-56-6 oxalic acid dihydrate 
• 59548-39-9 4-methoxyphenylene-1,2-diamine dihydrochloride 
• 96-96-8 4-methoxy-2-nitroaniline 
• 16133-49-6 5-methoxy-2-nitroaniline 
• 144-62-7 oxalic acid 
• 924-44-7 glyoxylic acid ethyl ester 
• 4685-47-6 3,4-dimethylanisole 
• 104-94-9 4-methoxy-aniline 
• 51-66-1 4-methoxyacetanilide 
• 119-81-3 4-methoxy-2-nitroacetanilide 
• 120951-69-1 N-(2-Formylamino-4-methoxy-phenyl)-formamide 

Downstream Products

• 39267-04-4 2,3-dichloro-6-methoxyquinoxaline 
• 69399-57-1 6-methoxy-7-nitroquinoxaline-2,3-dione 
• 60729-19-3 1,4-dimethyl-2,3-dioxo-6-methoxy-1,2,3,4-tetrahydroquinoxaline 
• 263715-90-8 3-chloro-7-methoxy-1-methylquinoxalin-2(1H)-one 
• 1261078-47-0 (2E,2'E)-diethyl 3,3'-(((6-methoxyquinoxaline-2,3-diyl)bis(azanediyl))bis(4,1-phenylene))diacrylate 
• 1206524-79-9 1-(tert-butyl) 2-methyl (2S,4R)-4-((3-chloro-7-methoxyquinoxalin-2-yl)oxy)pyrrolidine-1,2-dicarboxylate 
• 1361028-94-5 methyl (4R)-4-[(3-chloro-7-methoxyquinoxalin-2-yl)oxy]-L-prolinate hydrochloride 
• 55686-93-6 2-chloro-7-methoxyquinoxaline 

Relevant articles and documents

Novel molecular targeting anti-tumor aza-steroid derivative based on lipid toxicity and preparation and application thereof

The invention provides a novel molecular targeting anti-tumor aza-steroid derivative based on lipid toxicity and a preparation method and application thereof, and belongs to the field of chemical medicines. The derivative is a compound as shown in a formula I, or a salt thereof, or a stereoisomer thereof. The compound is low in toxicity or basically non-toxic to normal cells, has an obvious inhibition effect to tumor cell lines, particularly has good lipid toxicity selectivity to tumor cells such as liver cancer, lung cancer and the like in vivo, and has an obvious inhibition effect; meanwhile, the compound can effectively activate SREBP1 and PPAR gamma, inhibit lipid transport MTTP, cause lipid aggregation in tumor cells and cause lipid toxicity of the tumor cells. The compound can be used for treating liver cancer, lung cancer and the like in a molecular targeting manner, is low in toxicity or even non-toxic, and has a good application prospect.

NS3/4A protease inhibitor intermediate as well as synthesis method and application thereof

The invention belongs to the technical field of medicine, and particularly relates to an NS3/4A protease inhibitor intermediate as well as a synthesis method and application thereof. The synthesis method comprises the following steps: taking 4-methoxy-o-p

HEPATITIS C VIRUS NS3/4A PROTEASE INHIBITORS

The invention provides novel classes of HCV therapeutics that are orally available, safe and effective HCV NS3/4A protease inhibitors and are less susceptible to drug resistance than existing therapeutics. The invention also relates to pharmaceutical composition of these compounds and methods of preparation and use thereof.